Pharmaceutical pipeline worldwide by therapy area 2013-2017

This statistic shows the number of products in the global pharmaceutical pipeline for the period 2013-2017, broken down by therapy area. Over that period, it has been assessed that there are 53 pharmaceutical products in the pipeline for tuberculosis. It is evident that (ischaemic) heart disease, cancer and diabetes are the three top therapeutic areas regarding the R&D pipeline.

Number of products in the pharmaceutical R&D pipeline worldwide for the period 2013-2017, by therapy area*

Characteristic	Number of products in pipeline
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

November 2013

More information

Region

Worldwide

Survey time period

2013

Supplementary notes

* The number of products in the pipeline is defined as the number of compounds currently at a life cycle stage between Phase II clinical trials and registration. Pipeline measure for the period 2013-2017.
Abbreviations: IHD: Ischaemic Heart Disease; COPD: Chronic Obstructive Pulmonary Disease; LRI: Lower Respiratory Infection; BPH: Benign Prostatic Hyperplasia.

Open this statistic in...

Spanish

Citation formats